GlassScriptPhysician profile
Sean C Russell
NPI 1619399300
$9,440.48
in general payments reported to CMS, 2019-2025
19 companies · $2,598 in 2025
The $2,598 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $706 · 2022: $782 · 2023: $1,514 · 2024: $3,840 · 2025: $2,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,964 · Travel and Lodging: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,964.01 |
| Travel and Lodging | $987.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,028.61 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Si-Bone, INC. | $1,144.16 | 2021-2022 | |
| Abbott Laboratories | $700.44 | 2023-2025 | Eterna, Proclaim, Infinity |
| Medtronic, INC. | $524.63 | 2021-2025 | Synchromedii, Inceptiv, Plasmablade(Tm) |
| Livanova USA, INC. | $502.07 | 2025 | Vns Therapy |
| Nevro Corp. | $378.59 | 2024 | Senza |
| Alphatec Spine, INC | $307.50 | 2021-2022 | |
| Biotronik Nro, INC. | $300.00 | 2024 | Prospera |
| Penumbra, INC. | $166.63 | 2024-2025 | Penumbra System |
| Saluda Medical Americas, INC. | $132.55 | 2024 | Evoke |
| Depuy Synthes Sales INC. | $43.25 | 2023 | Symphony |
| Tricoast Surgical Solutions LLC | $42.74 | 2024 | |
| Becton, Dickinson and Company | $31.39 | 2024 | |
| Microvention, INC. | $27.43 | 2024 | Stent, Eric Retrieval Device |
| Globus Medical, INC. | $27.20 | 2025 | Senza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Augmedics INC. | $26.66 | 2025 | Xvision |
| Collegium Pharmaceutical, INC. | $24.33 | 2023 | Xtampza |
| Orthofix Medical, INC. | $16.45 | 2025 | Spinal-Stim |
| Merck Sharp & Dohme LLC | $15.85 | 2024 | Zerbaxa, Recarbrio, Dificid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.